WBI Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
WBI Investments's PFE Position: Q1 2026 in Review
WBI Investments reduced its Pfizer (PFE) stake by 14% in Q1 2026, selling an estimated $503K and leaving 114,615 shares worth $3.22M. The position accounts for 0.89% of the portfolio, ranked #16.
WBI Investments first reported a position in PFE in Q1 2014 and has held it in 21 quarters since. The position peaked at $29.4M in Q2 2018. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- WBI Investments held 114,615 shares of Pfizer worth $3.22M as of Q1 2026.
- WBI Investments sold 18,878 Pfizer shares in Q1 2026, an estimated $503K.
- Pfizer made up 0.89% of WBI Investments's portfolio in Q1 2026, its #16 holding.
- WBI Investments first reported a position in Pfizer in Q1 2014 and has held it in 21 quarters since.
- WBI Investments's Pfizer position peaked at $29.4M in Q2 2018.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.